Trial intelligence / Profile preview

Effectiveness of Fluoride Varnish Application as Cariostatic Agent in Irradiated Head and Neck Cancer Patients

TCTR20190327001Phase 1Recruiting

Sponsor
Institute of Medical Research and Technology Assessment
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of fluoride varnish in carious lesion and head and neck cancer (HNC), sponsored by Institute of Medical Research and Technology Assessment. Started Apr 2019; status: recruiting.

02

Drugs

fluoride varnish
03

Conditions

carious lesionhead and neck cancer (HNC)

Beyond the preview

Go deeper on TCTR20190327001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190327001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call